Actively Recruiting
Laparoendoscopic Rendezvous for Difficult Cholecystocholedocholithiasis
Led by Minia University · Updated on 2025-06-19
80
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Gallbladder stones combined with common bile duct stones, known as cholecystocholedocholithiasis, affect a notable number of patients and present challenges in treatment. This study focuses on patients experiencing difficult bile duct cannulation during endoscopic retrograde cholangiopancreatography (ERCP), a key procedure for stone removal. Researchers aim to evaluate the safety and effectiveness of the laparoendoscopic rendezvous (LERV) technique, which combines laparoscopic and endoscopic methods in a single operation to manage this condition. The study involves a single-stage procedure called laparoendoscopic rendezvous, which integrates laparoscopic cholecystectomy with intra-operative endoscopic sphincterotomy and stone removal. The technique includes an antegrade trans-cystic cannulation of the bile duct to aid endoscopic access, followed by stone clearance and the completion of gallbladder removal. The process has three main steps: the laparoscopic phase, the endoscopic phase, and completion. The study compares this approach against the traditional two-stage method involving pre-operative endoscopic sphincterotomy followed by laparoscopic cholecystectomy. Participants will undergo assessments during and after the procedure, including monitoring for successful bile duct cannulation, stone clearance, and complications such as pancreatitis, bleeding, bile leaks, perforation, cholangitis, and bile duct strictures. Follow-ups will assess short-term and long-term outcomes up to one year after the procedure. The study aims to provide detailed information on the effectiveness and safety of the laparoendoscopic rendezvous technique for treating difficult cholecystocholedocholithiasis.
CONDITIONS
Brief Title
Laparoendoscopic Rendezvous for Concomitant Gall Bladder Stones and Common Bile Duct Stones
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with stones in both the gallbladder and common bile duct confirmed by MRCP or ultrasound
- Patients with acute cholecystitis, acute cholangitis, obstructive jaundice, or high suspicion of common bile duct stones
- Patients with previous failed ERCP attempt
- Patients fit for general anesthesia and able to tolerate laparoscopic and endoscopic procedures
You will not qualify if you...
- History of hepatobiliary surgery such as choledochoduodenal anastomosis
- Previous upper abdominal surgery like total or partial gastric resection
- Morbid obesity
- Uncorrectable coagulopathy
- Refusal to give consent
- Pregnancy
- Suspected malignant biliary stricture or cholangiocarcinoma
- Severe acute cholangitis with instability or septic shock needing urgent drainage
- Impacted or very large common bile duct stones (over 1.5 cm)
- Severe cardiopulmonary disease raising operative risk
- Intrahepatic bile duct stones needing surgery
- Choledocholithiasis larger than 2 cm or too many stones difficult to remove
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - One day (single procedure)
Participants undergo a single-stage procedure combining laparoscopic cholecystectomy with intra-operative endoscopic sphincterotomy to remove gallbladder and common bile duct stones.
1 in-person surgical procedure visit
Duration - Up to 1 year after treatment
Participants are monitored after the procedure to assess recovery and detect any complications such as bleeding, pancreatitis, bile leak, perforation, cholangitis, or bile duct stricture.
Several follow-up visits up to 1 year
Trial Site Locations
Total: 1 location
1
Liver and GIT hospital , Minia University
Minya, Egypt, 61519
Actively Recruiting
Research Team
S
Saleh K Saleh, MD
A
Ayman M Hassanen, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here